ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

NCAB Cool On CCOP, Ponders Questions On Distribution, Numbers Of Centers

December 11, 1981

Funding Opportunities.

May 3, 2002

NCI Lists ARRA Funding By Organ Site

September 18, 2009

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994